United States · Bill · S
S. 1718 (106th)
Lifesaving Vaccine Technology Act of 1999
Introduced
12 October 1999
Last action
—
Status
Read twice and referred to the Committee on Finance.
Sponsors
—
Subjects
Discovery layer
Source updated
10 February 2026
Summary
Lifesaving Vaccine Technology Act of 1999 - Amends the Internal Revenue Code to establish an income tax credit for 30 percent of the qualified expenses (excluding amounts funded by any grant, contract, or otherwise by another person or any governmental entity) for medical research related to developing vaccines against malaria, tuberculosis, or HIV.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 12 October 1999
Introduced in Senate (PDF)
Introduced in Senate · EN · 12 October 1999
Introduced in Senate
summary · EN · 12 October 1999
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/106th-congress/senate-bill/1718
- Open data entity: https://api.congress.gov/v3/bill/106/s/1718